| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |